Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Applications of Liquid Biopsy Webinar Series - Colorectal Cancer

Aired live on 13 Oct 2021

ESMO-Webinar-Series-Applications-of-Liquid-Biopsy-Colorectal-Cancer-1000x250

Applications of Liquid Biopsy in Colorectal Cancer

Chair: Clara Montagut
Speakers: Jeanne Tie, Andrea Sartore-Bianchi

Learning objectives: 

  • Understand the concept and potential clinical applications of ctDNA in early-stage colorectal cancer in terms of detection of minimal residual disease and molecular relapse monitoring
  • Understand the concept and potential clinical applications of ctDNA for advanced cancer genotyping and evaluation of tumour response
  • Understand the concept and potential clinical applications of ctDNA to capture tumour evolution and drug resistance biomarkers

This webinar aims to review and discuss data for liquid biopsy-based assessments as endpoints of antitumour activity in clinical trials, understand the potential and limitations of liquid biopsy-based tumour genomic profiling for patient stratification and detection of predictive biomarkers of response to therapy, and to discuss how tumour heterogeneity and evolution assessed via liquid biopsy assays may improve colorectal cancer treatment strategies.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.